BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28534485)

  • 1. Pseudoexfoliation syndrome-associated genetic variants affect transcription factor binding and alternative splicing of LOXL1.
    Pasutto F; Zenkel M; Hoja U; Berner D; Uebe S; Ferrazzi F; Schödel J; Liravi P; Ozaki M; Paoli D; Frezzotti P; Mizoguchi T; Nakano S; Kubota T; Manabe S; Salvi E; Manunta P; Cusi D; Gieger C; Wichmann HE; Aung T; Khor CC; Kruse FE; Reis A; Schlötzer-Schrehardt U
    Nat Commun; 2017 May; 8():15466. PubMed ID: 28534485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients.
    Schlötzer-Schrehardt U; Pasutto F; Sommer P; Hornstra I; Kruse FE; Naumann GO; Reis A; Zenkel M
    Am J Pathol; 2008 Dec; 173(6):1724-35. PubMed ID: 18974306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysyl oxidase-like 1 gene in the reversal of promoter risk allele in pseudoexfoliation syndrome.
    Dubey SK; Hejtmancik JF; Krishnadas SR; Sharmila R; Haripriya A; Sundaresan P
    JAMA Ophthalmol; 2014 Aug; 132(8):949-55. PubMed ID: 24809751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
    Pasutto F; Krumbiegel M; Mardin CY; Paoli D; Lämmer R; Weber BH; Kruse FE; Schlötzer-Schrehardt U; Reis A
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1459-63. PubMed ID: 18385063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T allele of lysyl oxidase-like 1 rs41435250 is a novel risk factor for pseudoexfoliation syndrome and pseudoexfoliation glaucoma independently and through intragenic epistatic interaction.
    Guadarrama-Vallejo D; Miranda-Duarte A; Zenteno JC
    Mol Vis; 2013; 19():1937-44. PubMed ID: 24068861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of lysyl oxidase-like 1 gene common sequence variants in Greek patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
    Metaxaki I; Constantoulakis P; Papadimitropoulos M; Filiou E; Georgopoulos G; Chamchougia A; Papakonstantinou D; Markomichelakis N; Koutsandrea C; Halkiadakis I
    Mol Vis; 2013; 19():1446-52. PubMed ID: 23869164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective variant rs7173049 at LOXL1 locus impacts on retinoic acid signaling pathway in pseudoexfoliation syndrome.
    Berner D; Hoja U; Zenkel M; Ross JJ; Uebe S; Paoli D; Frezzotti P; Rautenbach RM; Ziskind A; Williams SE; Carmichael TR; Ramsay M; Topouzis F; Chatzikyriakidou A; Lambropoulos A; Sundaresan P; Ayub H; Akhtar F; Qamar R; Zenteno JC; Cruz-Aguilar M; Astakhov YS; Dubina M; Wiggs J; Ozaki M; Kruse FE; Aung T; Reis A; Khor CC; Pasutto F; Schlötzer-Schrehardt U
    Hum Mol Genet; 2019 Aug; 28(15):2531-2548. PubMed ID: 30986821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Pseudoexfoliation Glaucoma Risk-associated Variants Within Lysyl Oxidase-like 1 in an Irish Population.
    Eivers SB; Greene AG; Dervan E; O'Brien C; Wallace D
    J Glaucoma; 2020 Jun; 29(6):417-422. PubMed ID: 32102031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of LOXL1 polymorphisms with pseudoexfoliation, glaucoma, intraocular pressure, and systemic diseases in a Greek population. The Thessaloniki eye study.
    Anastasopoulos E; Coleman AL; Wilson MR; Sinsheimer JS; Yu F; Katafigiotis S; Founti P; Salonikiou A; Pappas T; Koskosas A; Katopodi T; Lambropoulos A; Topouzis F
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4238-43. PubMed ID: 24917141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttranscriptional Regulation of LOXL1 Expression Via Alternative Splicing and Nonsense-Mediated mRNA Decay as an Adaptive Stress Response.
    Berner D; Zenkel M; Pasutto F; Hoja U; Liravi P; Gusek-Schneider GC; Kruse FE; Schödel J; Reis A; Schlötzer-Schrehardt U
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5930-5940. PubMed ID: 29164236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations.
    Schlötzer-Schrehardt U
    Exp Eye Res; 2009 Apr; 88(4):776-85. PubMed ID: 18809397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of LOXL1 single nucleotide polymorphisms in Polish population with pseudoexfoliation syndrome.
    Malukiewicz G; Lesiewska-Junk H; Linkowska K; Mielnik M; Grzybowski T; Sulima N
    Acta Ophthalmol; 2011 Feb; 89(1):e64-6. PubMed ID: 21272281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological effect of LOXL1 coding variants associated with pseudoexfoliation syndrome.
    Sharma S; Martin S; Sykes MJ; Dave A; Hewitt AW; Burdon KP; Ronci M; Voelcker NH; Craig JE
    Exp Eye Res; 2016 May; 146():212-223. PubMed ID: 26997634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Lysyl Oxidase-Like 1 Gene Polymorphism in Turkish Patients With Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma.
    Asfuroglu M; Cavdarli B; Koz OG; A Yarangumeli A; Ozdemir EY
    J Glaucoma; 2017 Feb; 26(2):e54-e57. PubMed ID: 27753755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants and cellular stressors associated with exfoliation syndrome modulate promoter activity of a lncRNA within the LOXL1 locus.
    Hauser MA; Aboobakar IF; Liu Y; Miura S; Whigham BT; Challa P; Wheeler J; Williams A; Santiago-Turla C; Qin X; Rautenbach RM; Ziskind A; Ramsay M; Uebe S; Song L; Safi A; Vithana EN; Mizoguchi T; Nakano S; Kubota T; Hayashi K; Manabe S; Kazama S; Mori Y; Miyata K; Yoshimura N; Reis A; Crawford GE; Pasutto F; Carmichael TR; Williams SE; Ozaki M; Aung T; Khor CC; Stamer WD; Ashley-Koch AE; Allingham RR
    Hum Mol Genet; 2015 Nov; 24(22):6552-63. PubMed ID: 26307087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of the intronic
    Papadopoulou MK; Chatziralli I; Tzika K; Chiras D; Kitsos G; Kroupis C
    Ophthalmic Genet; 2021 Aug; 42(4):405-411. PubMed ID: 33792495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of high-risk alleles in the LOXL1 gene and its association with pseudoexfoliation syndrome and exfoliation glaucoma in a Latin American population.
    Jaimes M; Rivera-Parra D; Miranda-Duarte A; Valdés G; Zenteno JC
    Ophthalmic Genet; 2012 Mar; 33(1):12-7. PubMed ID: 21970694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LOXL1 genetic polymorphisms are associated with exfoliation glaucoma in the Japanese population.
    Mori K; Imai K; Matsuda A; Ikeda Y; Naruse S; Hitora-Takeshita H; Nakano M; Taniguchi T; Omi N; Tashiro K; Kinoshita S
    Mol Vis; 2008 Jun; 14():1037-40. PubMed ID: 18552979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LOXL1 variants in elderly Japanese patients with exfoliation syndrome/glaucoma, primary open-angle glaucoma, normal tension glaucoma, and cataract.
    Tanito M; Minami M; Akahori M; Kaidzu S; Takai Y; Ohira A; Iwata T
    Mol Vis; 2008; 14():1898-905. PubMed ID: 18958304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysyl oxidase-like 1 gene polymorphisms in German patients with normal tension glaucoma, pigmentary glaucoma and exfoliation glaucoma.
    Wolf C; Gramer E; Müller-Myhsok B; Pasutto F; Gramer G; Wissinger B; Weisschuh N
    J Glaucoma; 2010 Feb; 19(2):136-41. PubMed ID: 19373106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.